Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
No ADT
DRUG
2 trials
Sponsors
Asan Medical Center
, Istanbul University - Cerrahpasa
Conditions
Balance
Castration-resistant Prostate Cancer
Child
Core Stability
Demyelinating Diseases of the Central Nervous System
Fatigue
Phase 2
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
NCT01487902
Asan Medical Center
Castration-resistant Prostate Cancer
Start: 2010-07-31
Target: 90
Updated: 2011-12-08
Unknown Phase
Core Stability, Functional Capacity, Balance, Strength, and Fatigue in Pediatric Demyelinating Diseases
Not yet recruiting
NCT07654738
Istanbul University - Cerrahpasa
Balance, Child, Core Stability +2
Start: 2026-08-31
End: 2028-01-30
Target: 32
Updated: 2026-09-08
Related Papers
Randomized phase II trial of docetaxel plus prednisolone with or without androgen deprivation treatment in castration-resistant prostate cancer.
Journal of Clinical Oncology
2016-01-10
1 citations